Serum peptidomics profiling reveals fibrinogen alpha chain-derived peptides associated with clinical outcome in patients with heart failure
Open Access
- 17 November 2025
- journal article
- research article
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 25 (1) , 817
Abstract
There is an urgent need for effective risk prediction tools to assess all-cause mortality in heart failure (HF) patients, and recent serum peptidomics advancements may help identify potential biomarkers associated with HF outcome. We aimed to provide insights into the multiple biological processes and assess the predictive values of serum peptidomics in HF. We performed a prospective, nested, case-control study of 108 patients with HF. The serum peptides were measured by mass spectrometry in 27 healthy controls (HC), 27 patients who experienced all-cause death (event group), and 27 patients matched for age and sex who survived (non-event group) during 1-year follow-up. Bioinformatics analysis was conducted to identify changes in signaling pathways during the development of HF and screen candidate circulating peptides. We identified 1343 and 215 differential expressed peptides in the comparison between HF and HCs group and between the event and non-event group, respectively. Biological pathway analysis showed that the differentially expressed peptides were both mainly enriched in the coagulation and complement and coagulation cascades pathway. In addition, we identified key peptides with potential predictive value for HF outcome, particularly the fibrinogen alpha chain (FIBA)-derived peptides. Our findings suggest that the complement and coagulation pathway was associated with HF outcome. A FIBA-derived serum peptides model can serve as an outcome classifier in patients with HF.Keywords
Funding Information
- Beijing Municipal Public Welfare Development and Reform Pilot Project for Medical Research Institutes (JYY2023-9)
- National Natural Science Foundation of China (82400452)
This publication has 46 references indexed in Scilit:
- Peptides as “better biomarkers”? Value, challenges, and potential solutions to facilitate implementationMass Spectrometry Reviews, 2023
- Prognostic value of natriuretic peptides in heart failure: systematic review and meta-analysisHeart Failure Reviews, 2021
- The combination of carboxy‐terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy – A multilevel assessment of myocardial fibrosis in dilated cardiomyopathyEuropean Journal of Heart Failure, 2021
- Temporal trends in mortality and readmission after acute heart failure: a systematic review and meta‐regression in the past four decadesEuropean Journal of Heart Failure, 2021
- Heart Failure With Reduced Ejection FractionJAMA, 2020
- Uncovering the protective mechanism of Huoxue Anxin Recipe against coronary heart disease by network analysis and experimental validationBiomedicine & Pharmacotherapy, 2020
- Cardiac Contractility Modulation: Mechanisms of Action in Heart Failure with Reduced Ejection Fraction and BeyondEuropean Journal of Heart Failure, 2018
- Proteolysis in septic shock patients: plasma peptidomic patterns are associated with mortalityBritish Journal of Anaesthesia, 2018
- The challenges of peptidomics in complementing proteomics in a clinical contextMass Spectrometry Reviews, 2018
- Peptidomic Analysis of Maternal Serum to Identify Biomarker Candidates for Prenatal Diagnosis of Tetralogy of FallotJournal of Cellular Biochemistry, 2017